Mavyret 100 mg/1

Mavyret 100 mg/1 is a combination medication used to treat certain types of hepatitis C virus (HCV) infections. This oral tablet contains glecaprevir and pibrentasvir, designed for a specific antiviral therapy regimen.

Mavyret 100 mg/1 is primarily used for the treatment of chronic hepatitis C virus (HCV) infection. It is indicated for adults with specific genotypes of HCV, often in combination with other medications. The medication targets the virus to help manage the infection, aiming to reduce viral load and improve liver health.

Common effects of Mavyret 100 mg/1 may include fatigue, headache, nausea, and diarrhea. Some individuals might experience changes in liver function tests. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Mavyret 100 mg/1 should be handled with care, especially for those with liver disease or other chronic conditions. It is essential to follow the prescribed regimen and avoid self-adjustment of dosage. Regular medical check-ups are recommended during treatment.

Mavyret 100 mg/1 may interact with other medications, including certain antacids, HIV medications, and other drugs metabolized by the liver. It's crucial to inform healthcare providers about all current medications to avoid potential interactions.